Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Cancer
|
February 3, 2015
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies
John F Deeken, Hongkun Wang, Deepa Subramaniam, et al.
Journal of Hematology & Oncology
|
October 26, 2010
CyberKnife for hilar lung tumors: report of clinical response and toxicity
Keith Unger, Andrew Ju, Eric Oermann, et al.
Cancer Medicine
|
February 27, 2021
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies
Neel D Trivedi, Samantha Armstrong, Hongkun Wang, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 2013
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies
John F Deeken, Rebecca Slack, Glen J Weiss, et al.
Communications Biology
|
August 21, 2019
Electromagnetic fields alter the motility of metastatic breast cancer cells
Ayush Arpit Garg, Travis H Jones, Sarah M Moss, et al.
Cancer
|
December 29, 2015
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors
Miguel A Villalona-Calero, Elaine Lam, Gregory A Otterson, et al.
Journal of Hematology & Oncology
|
January 20, 2009
Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer
Brian T Collins, Saloomeh Vahdat, Kelly Erickson, et al.
Journal of Hematology & Oncology
|
June 11, 2010
CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures
Eric Oermann, Brian T Collins, Kelly T Erickson, et al.
The Journal of Clinical Investigation
|
June 10, 2014
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance
Kang-Seo Park, Mark Raffeld, Yong Wha Moon, et al.
Journal of Cancer Survivorship : Research and Practice
|
November 6, 2019
Implementation of the Smoking Treatment and Recovery (STAR) program: healthy cancer survivorship through integrated tobacco control
Kathryn L Taylor, Shelby Fallon, Deepa Subramaniam, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Cancer
|
February 3, 2015
A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies
John F Deeken, Hongkun Wang, Deepa Subramaniam, et al.
Journal of Hematology & Oncology
|
October 26, 2010
CyberKnife for hilar lung tumors: report of clinical response and toxicity
Keith Unger, Andrew Ju, Eric Oermann, et al.
Cancer Medicine
|
February 27, 2021
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies
Neel D Trivedi, Samantha Armstrong, Hongkun Wang, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 2013
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies
John F Deeken, Rebecca Slack, Glen J Weiss, et al.
Communications Biology
|
August 21, 2019
Electromagnetic fields alter the motility of metastatic breast cancer cells
Ayush Arpit Garg, Travis H Jones, Sarah M Moss, et al.
Cancer
|
December 29, 2015
Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors
Miguel A Villalona-Calero, Elaine Lam, Gregory A Otterson, et al.
Journal of Hematology & Oncology
|
January 20, 2009
Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer
Brian T Collins, Saloomeh Vahdat, Kelly Erickson, et al.
Journal of Hematology & Oncology
|
June 11, 2010
CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures
Eric Oermann, Brian T Collins, Kelly T Erickson, et al.
The Journal of Clinical Investigation
|
June 10, 2014
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance
Kang-Seo Park, Mark Raffeld, Yong Wha Moon, et al.
Journal of Cancer Survivorship : Research and Practice
|
November 6, 2019
Implementation of the Smoking Treatment and Recovery (STAR) program: healthy cancer survivorship through integrated tobacco control
Kathryn L Taylor, Shelby Fallon, Deepa Subramaniam, et al.
Page
of 2